RNA Breakthrough Targets Heavy Periods for Underserved Women

A team at Gujarat Biotechnology University, led by Prof. Rohini Nair, is set to develop innovative RNA-based diagnostic and therapeutic tools specifically for Heavy Menstrual Bleeding (HMB). This significant project has secured approximately Rs 1.3 crore in funding from the Gates Foundation's Grand Challenges, aiming to revolutionize menstrual health management.

The research endeavors to facilitate earlier detection and personalized treatment, with a particular focus on improving care for women in underserved communities. Heavy Menstrual Bleeding affects millions globally, leading to serious health issues like anemia and reduced quality of life, especially in low-resource settings where access to diagnosis and treatment is limited.

This initiative will map cellular and molecular drivers of HMB using single-cell RNA sequencing. The findings are expected to identify key biomarkers and pathways, paving the way for more effective interventions and increased accessibility to treatments like hormonal intrauterine devices, thereby addressing a persistent stigma and health gap.